
1. malar j. 2019 dec 19;18(1):434. doi: 10.1186/s12936-019-3070-x.

il35 modulation altered survival, cytokine environment histopathological
consequences malaria infection mice.

bello ro(1)(2), abdullah ma(3), abd majid r(4), chin vk(5), abd rachman isnadi
mf(1), ibraheem zo(6), hussain mk(7), magaji mg(2), basir r(8).

author information: 
(1)department human anatomy, faculty medicine health sciences,
university putra malaysia, 43400, serdang, selangor, malaysia.
(2)department pharmacology therapeutics, faculty pharmaceutical
sciences, ahmadu bello university, kaduna, 810107, nigeria.
(3)department pathology, faculty medicine health sciences, university
putra malaysia, 43400, serdang, selangor, malaysia.
(4)department medical microbiology parasitology, faculty medicine and
health sciences, university putra malaysia, 43400, serdang, selangor, malaysia.
(5)school biosciences, faculty health medical sciences, taylor's
university lakeside campus, 47500, subang jaya, malaysia.
(6)department pharmacology, faculty pharmacy, al rafidain university, al
mustansyria, baghdad, iraq.
(7)department biomedical sciences, faculty medicine health sciences,
university putra malaysia, 43400, serdang, selangor, malaysia.
(8)department human anatomy, faculty medicine health sciences,
university putra malaysia, 43400, serdang, selangor, malaysia.
rusliza@upm.edu.my.

background: immune modulating potential il-35 multiple human disorders 
has reported. consequent upon recognition inflammatory cytokine
activation preponderance mediating pathology malaria
infection, study aimed characterize expression functional
contribution(s) il-35 plasmodium berghei (strain anka) infected mice.
methods: plasmodium berghei infection male icr mice used rodent
model choice. time course il-35 expression systemic circulation 
and tissues p. berghei infected mice well healthy control
counterparts assessed enzyme linked immunosorbent assay and
immunohistochemistry respectively. effect modulating il-35 recombinant 
il-35 protein neutralizing anti-epstein-barr virus-induced gene 3 antibody 
the cytokine environment p. berghei infection assessed flow
cytometry. furthermore, influence modulating il-35 histopathological
hallmarks malaria disease progression evaluated.
results: interleukin-35 significantly regulated serum tissues p.
berghei infected mice correlated parasitaemia. neutralization il-35
significantly enhanced release ifn-Î³, decreased expression il-6 and
decreased parasitaemia patency. neutralization il-35 also associated 
a tendency towards increased survival well absence pathological
features associated malaria infection unlike recombinant il-35 protein
administration sustained normal course infection unfavourable
malaria associated histological outcomes p. berghei infected mice.
conclusion: results indicate involvement il-35 p. berghei induced
malaria infection. il-35 neutralization strategies may represent viable
therapeutic modalities beneficial resolution malaria infection.

doi: 10.1186/s12936-019-3070-x 
pmcid: pmc6923855
pmid: 31856836  [indexed medline]

